Presentation Information

[LS05-1]One year and eight months since the clinical implementation of anti-Aβ antibody drugs ―Now the role of MRI is being reconsidered―

Aya Tokumaru (Department of Diagnostic Radiology, Tokyo Metropolitan Institute for Geriatrics and Gerontology)

Comment

To browse or post comments, you must log in.Log in